{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:54Z","timestamp":1753890954738,"version":"3.41.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Big Data"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Biologics are considered as a promising novel treatment option for patients with chronic rhinosinusitis who failed with the standard of care (medical therapy and surgical interventions). This bibliometric analysis was performed to explore cross-border collaboration, communication, and research frontiers on biologics in chronic rhinosinusitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Original research publications on biologics in chronic rhinosinusitis were retrieved from the Science Citation Index-Expanded (SCI-E) database in the Web of Science Core Collection between 2004 and 2023. Using CiteSpace and R software, the country\/region, author, institution, journal, reference, and keywords were extracted to analyze the research focus and global trends in this field.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Research articles exhibited a consistent rising trend from 2004 to 2023, especially the period between 2020 and 2023. Most articles were published by authors from the USA. The USA was the most cited country, enjoying the most active cooperation with other countries\/regions. Bachert C owned the most publications and collaborations. Ghent University and Karolinska Institute had the most collaborations with other institutions. <jats:italic>Journal of Allergy and Clinical Immunology<\/jats:italic> and <jats:italic>Allergy<\/jats:italic> published the most articles and were the most co-cited journals. Research frontiers on biologics in chronic rhinosinusitis would focus on efficacy, quality of life, safety, children, management, etc.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This bibliometric analysis displayed the overall situation and global trend on biologics in chronic rhinosinusitis. The visualization analysis of publications could assist researchers rapidly in understanding the hotspots and trends. Further research is warranted to determine the long-term effects and side effects of biologics in chronic rhinosinusitis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fdata.2024.1428074","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T06:24:19Z","timestamp":1733120659000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Cross-border collaboration, communication, and research frontiers on biologics in chronic rhinosinusitis from 2004 to 2023"],"prefix":"10.3389","volume":"7","author":[{"given":"Guan-Jiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao-Qing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1111\/all.14809","article-title":"Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11882-018-0776-8","article-title":"Precision medicine in chronic rhinosinusitis with nasal polyps","volume":"18","author":"Avdeeva","year":"2018","journal-title":"Curr. Allergy Asthma. Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","article-title":"EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management","volume":"147","author":"Bachert","year":"2021","journal-title":"J. Allergy Clin. Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.15252\/embr.201439608","article-title":"Scientometrics in a changing research landscape: bibliometrics has become an integral part of research quality evaluation and has been changing the practice of research","volume":"15","author":"Bornmann","year":"2014","journal-title":"EMBO Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"g1585","DOI":"10.1136\/bmj.g1585","article-title":"References that anyone can edit: review of Wikipedia citations in peer reviewed health science literature","volume":"348","author":"Bould","year":"2014","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","article-title":"Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study","volume":"184","author":"Castro","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jaci.2022.04.013","article-title":"Current insight into treatment of chronic rhinosinusitis: phenotypes, endotypes, and implications for targeted therapeutics","volume":"150","author":"Chapurin","year":"2022","journal-title":"J. Allergy Clin. Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e12269","DOI":"10.1002\/clt2.12269","article-title":"Comparative short-term efficacy of endoscopic sinus surgery and biological therapies in chronic rhinosinusitis with nasal polyps: a network meta-analysis","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Allergy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"CD013513","DOI":"10.1002\/14651858.CD013513.pub2","article-title":"Biologics for chronic rhinosinusitis","volume":"2","author":"Chong","year":"2020","journal-title":"Cochrane Database Syst. Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4193\/Rhin22.489","article-title":"EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023","volume":"61","author":"Fokkens","year":"2023","journal-title":"Rhinology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J. Allergy Clin. Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMcp1800215","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"381","author":"Hopkins","year":"2019","journal-title":"N. Engl. J. Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/alr.22473","article-title":"The role of biologics in chronic rhinosinusitis: a systematic review","volume":"10","author":"Iqbal","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1097\/JS9.0000000000000492","article-title":"Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis","volume":"109","author":"Jiang","year":"2023","journal-title":"Int. J. Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/all.15074","article-title":"Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches","volume":"77","author":"Kato","year":"2022","journal-title":"Allergy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jaip.2022.03.002","article-title":"Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era","volume":"10","author":"Mullol","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1038\/jid.2014.123","article-title":"TNF-alpha gene polymorphisms: association with disease susceptibility and response to anti-TNF-alpha treatment in psoriatic arthritis","volume":"134","author":"Murdaca","year":"","journal-title":"J. Invest. Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1517\/17425255.2014.970165","article-title":"Pharmacogenetics of etanercept: role of TNF-alpha gene polymorphisms in improving its efficacy. Expert Opin. Drug Metab","volume":"10","author":"Murdaca","year":"","journal-title":"Toxicol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.eururo.2007.06.050","article-title":"bibliometric evaluation of publications in urological journals among European Union countries between 2000-2005","volume":"52","author":"Oelrich","year":"2007","journal-title":"Eur. Urol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40463-021-00493-2","article-title":"Canadian rhinology working group consensus statement: biologic therapies for chronic rhinosinusitis","volume":"50","author":"Thamboo","year":"2021","journal-title":"J. Otolaryngol. Head Neck Surg"}],"container-title":["Frontiers in Big Data"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdata.2024.1428074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T06:24:20Z","timestamp":1733120660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdata.2024.1428074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":22,"alternative-id":["10.3389\/fdata.2024.1428074"],"URL":"https:\/\/doi.org\/10.3389\/fdata.2024.1428074","relation":{},"ISSN":["2624-909X"],"issn-type":[{"type":"electronic","value":"2624-909X"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"article-number":"1428074"}}